Scholars Central

Short communicationPublished 2016

Relationship of Gender, Use of Disease-Modifying Therapies, and Health Insurance in Multiple Sclerosis

Authors: Guoqiao Wang, Amber R Salter

Journal of Clinical and Cellular Immunology

Volume 7 · Issue 6 · Pages 1–5

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Recent findings have demonstrated that use of disease-modifying therapies (DMTs) in persons with multiple sclerosis was affected by health insurance. Many patients relied on free or discounted drug programs for DMT use and when they obtained DMTs through their health insurance, it was not uncommon for them to experience insurance challenges for DMT use. However, it is not known how these findings were associated with gender. Here we investigate the association between gender and (1) DMT use, (2) use of free or discounted drug programs, and (3) insurance challenges for DMT use using participants from North American Research Committee on Multiple Sclerosis (NARCOMS) Registry.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Clinical and Cellular Immunology.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Clinical and Cellular Immunology
  • SubjectImmunology & Microbiology
  • BylineArticles whose byline prints “Guoqiao Wang”
  • BylineArticles whose byline prints “Amber R Salter”